Sarsia Seed AS is a Norwegian Seed Capital Fund which invests in Norwegian early phase technology companies within the energy/cleantech and biotechnology/life science sectors.

 


The fund has a total capital of 333.5 million NOK (approx, 40 mEUR/50 mUSD) and is managed by Sarsia Seed Management AS. The management company advises the Fund board regarding investment decisions. The Fund’s duration is expected to be 12 (+3) years.

 

The Management Team’s strength lay in its competence, experience and extensive national and international network of industrial players and co-investors. The Team’s collective experience comprises an optimal balance between operations, business and specialised technology know-how, applied research, and entrepreneurship; elements which are actively used both in the vetting and follow-up of investments.  

 

If you have an idea or technology which falls within our field of investments and require funding and expertise, then we encourage you to get in touch.

 

Sarsia Seed Management We are constantly on the look out for qualified people for key positions in our portfolio companies. If you feel that you have qualities which qualify you as such a candidate then please get in touch.

Sarsia Seed is part of a larger commercialisation and investment cluster located at the VilVite Centre which is a science discovery centre for the promotion of science and technology in Bergen.

Read More

NEWS

 

Vaccibody AS making headlines

Read more

 

Sarsia Seed has invested NOK 2 mill (€ 250.000) in the company Vaccibody.

Read more

 

WindSim and AXYS Join Forces to help Offshore Wind Developers

Read more

 

Weyland is strengthening it`s organization and is recruting a CEO.

Read more

 

Volusence  has received € 740.000 as a grant from Innovation Norway.

Read more

 

WindSim Launches US Subsidiary to Meet Increased Demand in the Wind Energy Industry

Appoints Software Industry Veteran Robert D. Buckley as President

Read more